REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Reacsys Diagnostics Saglik Hizmetleri A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Reacsys Diagnostics Saglik Hizmetleri Sanayi Ve Ticaret Anonim Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Reacsys Diagnostics Saglik Hizmetleri A.S. is an enterprise located in Turkiye, with the main office in Istanbul. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was established on March 18, 2004. It currently has a total number of 6 (2024) employees. From the latest financial highlights, Reacsys Diagnostics Saglik Hizmetleri A.S. reported a net sales revenue increase of 1493.61% in 2023. Its’ total assets recorded a growth of 15.58%. The enterprise’s net profit margin increased by 1659.77% in 2023.

Headquarters
No: 30a Barbaros Mahallesi Sen Sokak Atasehir
Istanbul; Marmara;

Contact Details: Purchase the Reacsys Diagnostics Saglik Hizmetleri A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Reacsys Diagnostics Saglik Hizmetleri A.S. report to view the information.
Financial Auditors:
Purchase the Reacsys Diagnostics Saglik Hizmetleri A.S. report to view the information.
Incorporation Date:
March 18, 2004
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Reacsys Diagnostics Saglik Hizmetleri A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
1493.61%▲
Total operating revenue
1493.61%▲
Operating profit (EBIT)
-72.4%▼
Net Profit (Loss) for the Period
-29.05%▼
Total assets
15.58%▲
Total equity
58.77%▲
Operating Profit Margin (ROS)
1613.01%▲
Net Profit Margin
1659.77%▲
Return on Equity (ROE)
106.1%▲
Quick Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo